Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carlla Assis Araujo-Silva"'
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 15, Iss , Pp 25-35 (2021)
The redirectioning of drugs in the pharmaceutical market is a well-known practice to identify new therapies for parasitic diseases. The histone deacetylase inhibitors Tubastatin A (TST) and Suberoylanilide Hydroxamic Acid (SAHA), firstly developed fo
Externí odkaz:
https://doaj.org/article/daca4fcef25c47c8a10401a0db52502f
Autor:
Rubens Belfort, Paulo Fernando Guimarães Morando Marzocchi Tierno, Carlla Assis Araujo-Silva, Victoria Sakamoto, Ana M C Branco, Mateus L Matuoka, Miguel N. Burnier, Paulo Schor, Allexya A A Marcos, Nara Franzin de Moraes, Andre C. Romano, Michel Eid Farah, Heloisa Nascimento, Alexandre Roque, Wanderley de Sousa, Paula M Marinho
Publikováno v:
JAMA Ophthalmol
Importance The presence of the SARS-CoV-2 virus in the retina of deceased patients with COVID-19 has been suggested through real-time reverse polymerase chain reaction and immunological methods to detect its main proteins. The eye has shown abnormali
Autor:
Mariana Galvão Ferrarini, Carlla Assis Araujo-Silva, Ariel Mariano Silber, Andréa Rodrigues Ávila, Ana Paula Ressetti Abud, Marie France-Sagot, Rossiane C. Vommaro, Alan de Almeida Veiga, Sheila Cristina Nardelli, Lindice Mitie Nisimura, Mayke Bezerra Alencar, Richard M. B. M. Girard, Mariana Sayuri Ishikawa Fragoso
Publikováno v:
MSphere
MSphere, American Society for Microbiology., 2021, 6 (1), ⟨10.1128/mSphere.01002-20⟩
MSphere, 2021, 6 (1), ⟨10.1128/mSphere.01002-20⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
mSphere
mSphere, Vol 6, Iss 1 (2021)
MSphere, American Society for Microbiology., 2021, 6 (1), ⟨10.1128/mSphere.01002-20⟩
MSphere, 2021, 6 (1), ⟨10.1128/mSphere.01002-20⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
mSphere
mSphere, Vol 6, Iss 1 (2021)
Currently, the drugs used for toxoplasmosis have severe toxicity to human cells, and the treatment still lacks effective and safer alternatives. The search for novel drug targets is timely.
Toxoplasmosis, a protozoan infection caused by Toxoplas
Toxoplasmosis, a protozoan infection caused by Toxoplas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a8a95fdb242e3365446dc091cb7126
https://hal.inria.fr/hal-03104886/file/mSphere-2021-Ferrarini-e01002-20.full.pdf
https://hal.inria.fr/hal-03104886/file/mSphere-2021-Ferrarini-e01002-20.full.pdf
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance
International Journal for Parasitology: Drugs and Drug Resistance, Vol 15, Iss, Pp 25-35 (2021)
International Journal for Parasitology: Drugs and Drug Resistance, Vol 15, Iss, Pp 25-35 (2021)
The redirectioning of drugs in the pharmaceutical market is a well-known practice to identify new therapies for parasitic diseases. The histone deacetylase inhibitors Tubastatin A (TST) and Suberoylanilide Hydroxamic Acid (SAHA), firstly developed fo